Comparative study on effects of pentoxifylline, prednisolone and colchicine in experimental alveolitis

International Journal of Immunopharmacology

Volumn 20, Issue 12, 1998, Pages 723-735

  Entzian, P ^a   Zahringer U ^a   Schlaak, M ^a   Gerlach, C ^b   Galle, J ^a   Zabel, P ^a  

^a Department of Clinical Medicine ^*  (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Alveolitis; Bleomycin; Colchicine; Pentoxifylline; Prednisolone; Rat; Therapy

Indexed keywords

BLEOMYCIN; COLCHICINE; PENTOXIFYLLINE; PREDNISOLONE;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FIBROSING ALVEOLITIS; INFLAMMATORY CELL; LUNG ALVEOLITIS; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; COLCHICINE; COLLAGEN; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG; MALE; NEUTROPHILS; PENTOXIFYLLINE; PLATELET AGGREGATION INHIBITORS; PREDNISOLONE; PULMONARY FIBROSIS; RATS; RATS, INBRED F344;

EID: 0344505269     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00056-3     Document Type: Article

References (43)

1. Berman B., Wietzerbin J., Sanceau J., Merlin G., Duncan M. R. J. Invest. Dermatol. 98:1992;706-712.
2. Ciufetti G., Mercury M., Ott C., Lombardini R., Paltricia R., Lupattelli G., Santambrogio L., Mannarino E. Eur. J. Clin. Pharmacol. 41:1991;511-515.
3. Costabel, U. (1994). Atlas der bronchoalveolären Lavage. Stuttgart: Georg Thieme Verlag.
4. Crouch E. Am. J. Physiol. 159:1990;184.
5. Diegelmann R. F., Peterkofsky B. Proc. Natl. Acad. Sci. U.S.A. 69:1972;892-896.
6. Douglas W. W., Ryu J. H., Bjoraker J. A., Schroeder D. R., Myers J. L., Tazelaar H. D., Swensen S. J., Peters S. G., DeRemee R. A. Mayo. Clin. Proc. 72:1997;201-209.
7. Ehrlich H. P., Ross R., Bornstein P. A biochemical and morphological study. 62:1974;390-405.
8. Entzian P., Schlaak M, Seitzer U., Bufe A., Acil Y., Zabel P. Lung. 175:1997;41-51.
9. Entzian P., Schlaak M., Seitzer U., Yahya A., Ernst M., Zabel P. Mediators of Inflammation. 6:1997;1-8.
10. Gerdes J., Lemke H., Baisch H., Wacker H., Schwab U., Stein H. J. Immunol. 133:1984;1710-1715.
11. Gerlach C., Gerdes J., Hahn M., Baron B., Heinemann G., Kemmler R., Flad H. D., Larue L. CellProliferation. 28:1995;207.
12. Gottlöber P., Krähn G., Korting H. C., Stock W., Peter R. U. Ein Erfahrungsbericht. 172:1996;34-38.
13. Hammerschmidt D. E., Kotasek D., McCarthy T., Huh P. W., Freyburger G., Vercellotti G. M. J. Lab. Clin. Med. 112:1988;254-263.
14. Keogh B. A., Bernardo J., Hunninghake G.W., Line B. R., Price D. L., Crystal R. G. Am. Rev. Respir. Dis. 127:1983;18-22.
15. Kershenobich D., Vargas F., Garcia-Tsao G., Tamayo R. P., Gent M., Rojkind M. N. Engl. J. Med. 318:1988;1709-1713.
16. Knapp, D. R. (1979). Handbook of analytical derivatization reactions. New York: John Wiley and Sons, Inc.
17. Levy M., Spino M., Read S. E. Pharmacotherapy. 11:1991;196-211.
18. Mapel D. W., Samet J. M., Coultas D. B. Chest. 110:1996;1058-1067.
19. Meier-Sydow J., Weiss S. M., Buhl R., Rust M., Raghu G. Semin. Respir. Crit. Care. Med. 15:1994;77-96.
20. Moore S. J. Biol. Chem. 243:1968;6281-6283.
21. Nettelbladt O., Tengblad A., Hällgren R. Eur. Respir. J. 3:1990;421-428.
22. ODonnell K., Keogh B., Cantin A., Crystal R. G. Am. Rev. Respir. Dis. 136:1987;288-292.
23. Panos R. J., Mortenson R. L., Niccoli S.A., King T. E. J. Am. J. Med. 88:1990;396-404.
24. Park J., Kim I., Park R., Jo J. Korean. J. Biochem. 22:1990;39-46.
25. Peters S. G., McDougall J. C., Douglas W.W., Coles D. T., deRemee R. A. Chest. 103:1993;101-104.
26. Peterson T. C. Hepatology. 17:1993;486-493.
27. Phan S. H., Thrall R. S., Ward P. A. Am. Rev. Respir. Dis. 121:1980;501-506.
28. Piguet P. F., Collart M. A., Grau G. E., Kapanci Y., Vassalli P. J. Exp. Med. 170:1989;655-663.
29. Raghow R., Thompson J. P. Mol. Cell. Biol. 86:1989;5-18.
30. Samlaska M. C. P., Winfield E. A. J. Am. Acad. Dermatol. 30:1994;603-621.
31. Schade U. F. Eicosanoids. 2:1989;183-188.
32. Schwartz D. A., van Fossen D. S., Davis C. S., Helmers R. A., Dayton C. S., Burmeister L. F., Hunninghake G. W. Am. J. Respir. Crit. Care Med. 149:1994;444-449.
33. Schwartz D. A., Helmers R. A., Galvin J. R., van Fossen D. S., Frees K. L., Dayton C. S., Burmeister L. F., Hunninghake G. W. Am. J. Respir. Crit. Care Med. 149:1994;450-454.
34. Semmler J., Gebert U., Eisenhut T., Moeller J., Schönharting M. M., Allera A., Endres S. Immunol. 78:1993;520-525.
35. The BAL Co-operative Group Steering Committee. Am. Rev. Respir. Dis. 141:1990;188-192.
36. Tiegs G., Freudenberg M. A., Galanos C., Wendel A. Infect. Immun. 60:1992;1941-1945.
37. Turner-Warwick M., Haslam P. L. Am. Rev. Respir. Dis. 135:1987;26-34.
38. Ward A., Clissold S. P. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy. 34:1987;50-97.
39. Zabel, P., Greinert, U., Entzian, P., and Schlaak, M. (1993). Effects of pentoxifylline on circulating cytokines (TNF and IL-6) in severe pulmonary tuberculosis. In W. Fiers and W. A. Buurman (Eds.), Tumor necrosis factor: molecular and cellular biology and clinical relevance. (pp. 178-181). Basel: Karger.
40. Zabel P., Schade F. U. Immunol. 3:1993;175-180.
41. Zabel P., Bitter-Suermann S., Entzian P., Ernst M., Schlaak M. Eur. Respir. J. 23:1996;3.
42. Zabel P., Entzian P., Dalhoff K., Schlaak M. Am. J. Respir. Crit. Care. Med. 155:1997;1665-1669.
43. Zhang L., Zhu Y., Luo W., Xi P., Yan Y. Chin. Med. Sci. J. 7:1992;58-60.